Sort
17,828 grants matching “crispr”
Develop, Optimize and Commercialize UltraMarathonRT: A new enzyme for unbiased transcriptomic and epitranscriptomic characterization of RNAs regardless of length or composition.
$1,555,946Li-Tao Guo · Rnaconnect Inc · R44 · FY2024 · GM
Deciphering microbial virulence mechanisms during Legionella pneumophila infection
$1,554,862Matthias Machner · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
High throughput CRISPR-mediated functional validation of regulatory elements
$1,552,831Yin Shen · University Of California, San Francisco · UM1 · FY2020 · HG
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
$1,552,630Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Novel Therapeutics for FSHD
$1,552,437Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2019 · HD
Establishing patient-derived iPSCs as a platform for discovery research in NAFLD
$1,550,397Jacquelyn J. Maher · University Of California, San Francisco · RC2 · FY2024 · DK
NEI Genetic Engineering Core
$1,548,127Lijin Dong · National Eye Institute · ZIC · FY2017 · EY
NIEHS Gene Editing and Mouse Model (GEMM) Core Annual Report
$1,546,971Manas Ray · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES
Ribosome quality control
$1,546,622Colin Wu · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Combinatorial Actions of Genetic Variants and Gender Bias of Alzherimer's Disease
$1,545,510Michael G Rosenfeld · University Of California, San Diego · R01 · FY2019 · AG
Research Capacity Core
$1,544,855Josiah Ochieng · Meharry Medical College · U54 · FY2022 · MD
Cell Type-Specific Proteins that Promote Resilience to Cognitive Aging and Alzheimer's Disease
$1,544,773Catherine Cook Kaczorowski · University Of Michigan At Ann Arbor · R01 · FY2024 · AG
Functional Genomics Laboratory (FGL)
$1,542,975Anton Simeonov · National Center For Advancing Translational Sciences · ZIC · FY2023 · TR
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
$1,542,693Paul Stephen Keim · Northern Arizona University · U19 · FY2023 · AI
Novel Therapeutics for FSHD
$1,541,442Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2022 · HD
Novel Therapeutics for FSHD
$1,541,442Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2021 · HD
Novel Therapeutics for FSHD
$1,541,442Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2020 · HD
iPSC-based Model to Study Frontotemporal Dementia Due to MAPT Mutation
$1,540,579Sally Temple · Regenerative Research Foundation · RF1 · FY2025 · NS
Development Of New Chemotherapeutics For Tuberculosis
$1,538,298Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
High-throughput in vivo and in vitro functional and multi-omics screens of neuropsychiatric and neurodevelopmental disorder risk genes
$1,537,668Ellen J Hoffman · Yale University · RM1 · FY2025 · MH
iPS-technology and patient specific disease models
$1,537,608Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Pathogenesis and Treatment of HIV Infection
$1,532,886H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Evolutionary dynamics and microenvironmental determinants of metastatic breast cancer
$1,532,156Christina N Curtis · Stanford University · U54 · FY2023 · CA
Cellular and Molecular Physiology of Bloodstream Malaria Parasites
$1,530,783Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
$1,530,461Paul Stephen Keim · Northern Arizona University · U19 · FY2025 · AI